Suraksha Diagnostic, a prominent diagnostic chain located in Eastern India, held an informative scientific session on Advances in Genetics and Reproductive Health. The attendees heard from highly regarded experts from around the globe on the...
AbbVie received an approval from the U.S. Food and Drug Administration (FDA) to a supplemental new drug application (sNDA) for RINVOQ (upadacitinib).
.png "Roche Showcases Groundbreaking Cancer Research at ESMO 2025")
Roche announced it will present over 30 abstracts on more than 10 different types of cancer at the European Society for Medical Oncology (ESMO) Congress 2025, highlighting its commitment to progressing cancer care.
Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), among the 10 leading fixed-dosage injectable manufacturers in the world, has inaugurated its state-of-the-art Venus Global Fulfillment Center (VGFC).
Zen Multi-Specialty Hospital, Chembur, has been recognized by the Asia Book of Records for hosting a record-setting live laparoscopic surgery broadcast known as 'Laparoscopy Unlimited' with a total participation of 2635 medical professionals plus...
The Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with the Serum Institute of India (SII) Pvt. Ltd. the world’s largest vaccine manufacturer and part of the Cyrus Poonawalla Group to strengthen global pandemic preparedness
In a significant public health milestone, the World Health Organization (WHO) has recognized the Maldives for successfully eliminating mother-to-child transmission (EMTCT) of hepatitis B, while also upholding its previous validation (in 2019) for EMT
Pfizer Inc. will be presenting the latest developments of their infectious disease portfolio at IDWeek 2025 from October 19-22, 2025.
Bristol Myers Squibb (BMS) has made it clear that he is bringing Kopozgo (Mavacamten) to the Indian market. This is the first and only oral, selective cardiac myosin inhibitor for New York Heart Association (NYHA) Class II–III
Aurobindo Pharma's promoter group has successfully secured around 2,000 crore with a dual-tranche financing structure intended for platform acquisitions, which includes the Taj Banjara asset situated in Hyderabad. The funds are being directed
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")